Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Top drugs by sales in 2017: Who sold the blockbuster drugs?
The year 2017 was a landmark year for pharmaceutical
industries in the US and Europe, with a sharp i
Chemical entities SHINE in the top 10 fastest-growing drugs of 2016
Global
pharmaceutical companies are increasingly focusing on the development of new
biologics. In fa
Top drugs by sales in 2016: Who sold the blockbuster drugs?
The year 2016 finished with a whimper insofar as mergers and acquisitions (M&As) were concerned.
Capsugel’s U.S. plant has data-integrity issues, billion dollar Chinese bid for Indian sterile manufacturer, Pfizer & Mylan’s dermatology bet
This week’s Phispers has regulatory and M&A news from across the world as Pfizer ends its
